Through this strategy, our results suggested that epistatic interactions between PDK2 and ABCG2 contributed to serum urate and gout and that PKD2 is supposed to influence the progression from elevated serum urate to hyperuricemia to gout by epistatically interacting with ABCG2. Here, ABCG2 is linked to hyperuricemia.